FDA Approves Moderna's Coronavirus Vaccine

A week after the FDA approved the Pfizer/BioNTech coronavirus vaccine for emergency use, the agency has granted the same approval for Moderna's vaccine. In clinical trials, Moderna's candidate was over 94 percent effective.

On Thursday night, the Vaccines and Related Biological Products Advisory Committee voted 20-0 to recommend the vaccine be made available.

"The evidence that has been studied in great detail on this vaccine highly outweighs any of the issues we’ve seen," said Dr. Hayley Gans of Stanford University Medical Center.

HHS Secretary Alex Azar said Wednesday that the Trump administration has 5.9 million doses of the Moderna vaccine for immediate release.

The Pfizer vaccine has already been administered to health care workers around the country. Vice President Pence received the shot during a televised event on Friday, along with second lady Karen Pence and Surgeon General Jerome Adams.